AVITA Medical (RCEL) Interest Coverage Ratio (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.35% |
| Sep 30, 2025 | 18.93% |
| Jun 30, 2025 | 7.17% |
| Mar 31, 2025 | -136.99% |
| Dec 31, 2024 | 355.26% |
| Sep 30, 2024 | 12.42% |
| Jun 30, 2024 | 8.59% |
| Mar 31, 2024 | -16.00% |
| Dec 31, 2023 | 98.82% |
| Sep 30, 2023 | 41.66% |
| Jun 30, 2023 | 35.63% |
| Mar 31, 2023 | -192.89% |
| Dec 31, 2022 | 378.44% |
| Sep 30, 2021 | -26.47% |
| Jun 30, 2021 | 73.83% |
| Mar 31, 2021 | -6.39% |
| Dec 31, 2020 | -28.64% |
| Sep 30, 2020 | 10.37% |
| Jun 30, 2020 | 47.17% |
| Mar 31, 2020 | -202.65% |
| Dec 31, 2019 | 1,002.64% |
| Sep 30, 2019 | 51.17% |
| Jun 30, 2019 | 49.02% |
| Mar 31, 2019 | -6.02% |
| Dec 31, 2018 | -49.47% |
| Sep 30, 2018 | -226.93% |